Sagimet Biosciences Inc (SGMT)
4.97
-0.10
(-1.97%)
USD |
NASDAQ |
Dec 20, 16:00
5.22
+0.25
(+5.03%)
After-Hours: 20:00
Sagimet Biosciences Shareholders Equity (Quarterly): 170.68M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 777.16M |
| Y-mAbs Therapeutics Inc | 92.43M |
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 2.912M |
| IGC Pharma Inc | 7.377M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 174.78M |
| Total Liabilities (Quarterly) | 4.092M |